IXICO PHYOF Stock
IXICO Price Chart
IXICO PHYOF Financial and Trading Overview
| IXICO stock price | 0.77 USD |
| Previous Close | 0.07 USD |
| Open | 0.15 USD |
| Bid | 0.07 USD x 800000000 |
| Ask | 0 USD x 0 |
| Day's Range | 0.15 - 0.15 USD |
| 52 Week Range | 0.07 - 0.15 USD |
| Volume | 1K USD |
| Avg. Volume | 0 USD |
| Market Cap | 167.9M USD |
| Beta (5Y Monthly) | 0.07 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PHYOF Valuation Measures
| Enterprise Value | 5.37M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 23.078575 |
| Price/Book (mrq) | 4.9336505 |
| Enterprise Value/Revenue | 0.738 |
| Enterprise Value/EBITDA | -2.013 |
Trading Information
IXICO Stock Price History
| Beta (5Y Monthly) | 0.07 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 0.15 USD |
| 52 Week Low | 0.07 USD |
| 50-Day Moving Average | 0.07 USD |
| 200-Day Moving Average | 0.07 USD |
PHYOF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 218.05M |
| Float | 41.02M |
| Short Ratio | N/A |
| % Held by Insiders | 4.88% |
| % Held by Institutions | 82.94% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | September 30, 2026 |
Profitability
| Profit Margin | -24.97% |
| Operating Margin (ttm) | -31.42% |
| Gross Margin | 50.76% |
| EBITDA Margin | -36.67% |
Management Effectiveness
| Return on Assets (ttm) | -13.23% |
| Return on Equity (ttm) | -15.79% |
Income Statement
| Revenue (ttm) | 7.28M USD |
| Revenue Per Share (ttm) | 0.08 USD |
| Quarterly Revenue Growth (yoy) | 23.10% |
| Gross Profit (ttm) | 3.69M USD |
| EBITDA | -2668000 USD |
| Net Income Avi to Common (ttm) | -1817000 USD |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.68M USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 559K USD |
| Total Debt/Equity (mrq) | 5.22 USD |
| Current Ratio (mrq) | 2.833 |
| Book Value Per Share (mrq) | 0.15607104 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2145000 USD |
| Levered Free Cash Flow (ttm) | -3181375 USD |
Profile of IXICO
| Country | United States |
| State | N/A |
| City | London |
| Address | Griffin Court |
| ZIP | EC1A 9PN |
| Phone | 44 20 3763 7499 |
| Website | https://ixico.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 79 |
IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such as radiological reads, volumetric MRI, PET and SPECT, and advanced MRI; trial management; data analytics; post marketing surveillance and clinical diagnostics; and consultancy services. In addition, the company offers IXICO platform, an AI-enabled technology platform for neuroimaging data management and analysis. Its services are used for various therapeutic areas comprising Alzheimer's, Huntington's, Multiple Sclerosis, and Parkinson's diseases, as well as other rare neurological diseases, other Demyelinating disorders, and other Parkinsonian disorders. It has collaboration with Medidata to create neuroimaging clinical trials platform. The company is based in London, the United Kingdom.
Q&A For IXICO Stock
What is a current PHYOF stock price?
IXICO PHYOF stock price today per share is 0.77 USD.
How to purchase IXICO stock?
You can buy PHYOF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IXICO?
The stock symbol or ticker of IXICO is PHYOF.
Which industry does the IXICO company belong to?
The IXICO industry is Biotechnology.
How many shares does IXICO have in circulation?
The max supply of IXICO shares is 218.05M.
What is IXICO Price to Earnings Ratio (PE Ratio)?
IXICO PE Ratio is now.
What was IXICO earnings per share over the trailing 12 months (TTM)?
IXICO EPS is -0.05 USD over the trailing 12 months.
Which sector does the IXICO company belong to?
The IXICO sector is Healthcare.